Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.

about

Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.

Item

http://www.wikidata.org/entity/Q49583254

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.

@en

Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.

@nl

type

Item

label

Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.

@en

Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.

@nl

prefLabel

Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.

@en

Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.

@nl

P1476

Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.

@en

P2093

Daniel Goldman

http://www.w3.org/2001/XMLSchema#string

Dwayne N Jackson

http://www.w3.org/2001/XMLSchema#string

Heidi A Kluess

http://www.w3.org/2001/XMLSchema#string

Leslie E Neidert

http://www.w3.org/2001/XMLSchema#string

Mohammed Al-Tarhuni

http://www.w3.org/2001/XMLSchema#string

P2860

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides.

Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion.

The dimeric transmembrane domain of prolyl dipeptidase DPP-IV contributes to its quaternary structure and enzymatic activities.

Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes.

Paradoxical impairment of angiogenesis, endothelial function and circulating number of endothelial progenitor cells in DPP4-deficient rat after critical limb ischemia.

Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells

Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?

Influence of estradiol supplementation on neuropeptide Y neurotransmission in skeletal muscle arterioles of F344 rats.

P31

scholarly article

P356

10.14814/PHY2.13564

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29380955

http://www.w3.org/2001/XMLSchema#string

P932

5789721

http://www.w3.org/2001/XMLSchema#string